Filter Results:
(1,470)
Show Results For
- All HBS Web
(1,470)
- People (7)
- News (354)
- Research (918)
- Multimedia (2)
- Faculty Publications (436)
Show Results For
- All HBS Web
(1,470)
- People (7)
- News (354)
- Research (918)
- Multimedia (2)
- Faculty Publications (436)
- February 2014
- Article
Developing a System to Track Meaningful Outcome Measures in Head and Neck Cancer Treatment
By: Ronald S. Walters, Heidi W. Albright, Randal S. Weber, Thomas W. Feeley, Ehab Y. Hanna, Scott B. Cantor, Carol M. Lewis and Thomas W. Burke
The health care industry, including consumers, providers, and payers of health care, recognize the importance of developing meaningful, patient-centered measures. This article describes our experience using an existing electronic medical record largely based on free... View Details
Keywords: Cancer Treatment; Cancer Care In The U.S.; Outcomes Measurement; Health Care and Treatment; Measurement and Metrics; Health Industry; North and Central America
Walters, Ronald S., Heidi W. Albright, Randal S. Weber, Thomas W. Feeley, Ehab Y. Hanna, Scott B. Cantor, Carol M. Lewis, and Thomas W. Burke. "Developing a System to Track Meaningful Outcome Measures in Head and Neck Cancer Treatment." Head & Neck 36, no. 2 (February 2014): 226–230. (e-Pub 6/2013. PMID: 23729280.)
- December 2023
- Article
Association of Hospital System Affiliation with COVID-19 Capacity Burden
By: Zachary Levin, Pinar Karaca-Mandic, Richard J. Boxer and Regina E. Herzlinger
What is the message? The COVID-19 pandemic exposed the highly variable and uncoordinated responses by hospitals. The authors found that while the non-top ten system affiliated hospitals had a larger COVID-19 share index relative to independent hospitals, top-ten system... View Details
Keywords: COVID-19 Pandemic; Resource Allocation; Health Pandemics; Demographics; Health Care and Treatment; Health Industry
Levin, Zachary, Pinar Karaca-Mandic, Richard J. Boxer, and Regina E. Herzlinger. "Association of Hospital System Affiliation with COVID-19 Capacity Burden." Health Management, Policy and Innovation 8, no. 3 (December 2023).
- June 21, 2019
- Article
When Tech Companies Compete on Their Own Platforms
By: Feng Zhu
One common complaint from third parties about platform businesses is that they see what succeeds on their platforms and then enter the most profitable areas themselves, often decimating third parties in the process. Studies have identified several motivations for... View Details
Keywords: Platform-based Markets; Platform-owner Entry; Digital Platforms; Market Entry and Exit; Competition
Zhu, Feng. "When Tech Companies Compete on Their Own Platforms." Harvard Business Review (website) (June 21, 2019).
- Web
Rare Disease Day – Small Numbers, Big Challenges… and Big Opportunities - Blog: Health Supplement
lead to lower social engagement due to lack of care options , or resources through the healthcare system. Growing up with a condition that causes regular nosebleeds and life-threatening debilitations was... View Details
- May 2014 (Revised January 2015)
- Case
Vaxess Technologies, Inc.
By: John A. Quelch and Margaret L. Rodriguez
In February 2014, Michael Schrader, chief executive of Vaxess Technologies, Inc., was assessing the startup health care company's 2014 marketing plan. On December 31st, 2013, Vaxess had obtained an exclusive license to a series of patents for a silk protein technology... View Details
Keywords: Vaccine; Cold Chain; Antigen; Temperature Controlled; Developing Markets; Immunization; Health Care and Treatment; Health Pandemics; Global Strategy; Supply Chain; Health; Health Industry; Health Industry
Quelch, John A., and Margaret L. Rodriguez. "Vaxess Technologies, Inc." Harvard Business School Case 514-107, May 2014. (Revised January 2015.)
- January 2014 (Revised January 2014)
- Case
Henry Schein: Doing Well by Doing Good?
By: Rebecca Henderson, Raffaella Sadun, Aldo Sesia and Russell Eisenstat
Henry Schein Inc., a distributor of supplies to dentist, physician, and veterinary practices, had sales approaching $9 billion and employed nearly 16,000 people. The company had experienced impressive growth under the leadership of Stanley Bergman and his executive... View Details
Keywords: Leadership Development; Strategy Execution; Performance Management; Corporate Culture; Social Responsibility; Mergers & Acquisitions; Joint Ventures; Partnerships; Health Care Industry; Healthcare Logistics Industry; Competitive Advantage; Strategy; Leadership; Global Strategy; Selection and Staffing; Management Style; Organizational Culture; Corporate Social Responsibility and Impact; Health Industry; Health Industry; China; Europe; United States
Henderson, Rebecca, Raffaella Sadun, Aldo Sesia, and Russell Eisenstat. "Henry Schein: Doing Well by Doing Good?" Harvard Business School Case 714-450, January 2014. (Revised January 2014.)
- October 2013
- Case
Pearle Vision: Clearly Different?
By: Rajiv Lal and Natalie Kindred
Ohio-based optical retailer Pearle Vision, part of the vertically integrated Italian eyewear group Luxottica, sold glasses and offered in-store eye exams. Once the largest U.S. optical retailer, Pearle Vision, with 266 corporate stores and 356 franchised stores in... View Details
Keywords: Eye Care; Competitive Advantage; Market Participation; Health Industry; Health Industry; United States
Lal, Rajiv, and Natalie Kindred. "Pearle Vision: Clearly Different?" Harvard Business School Case 514-015, October 2013.
- January 2015 (Revised July 2019)
- Case
CVS Health: Promoting Drug Adherence
Email mking@hbs.edu for a courtesy copy.
The case describes a program that CVS Health recently implemented to improve medication adherence, an important problem from a societal, public policy, and firm... View Details
The case describes a program that CVS Health recently implemented to improve medication adherence, an important problem from a societal, public policy, and firm... View Details
Keywords: Medication Adherence; Affordable Care Act (ACA); Marketing Strategy; Communication Strategy; Customer Value and Value Chain; Decisions; Health Care and Treatment; Goals and Objectives; Resource Allocation; Marketing Communications; Consumer Behavior; Measurement and Metrics; Service Delivery; Behavior; Motivation and Incentives; Social Issues; Information Technology; Value Creation; Health Industry; Health Industry; Health Industry; Health Industry; Health Industry; United States
John, Leslie, John Quelch, and Robert Huckman. "CVS Health: Promoting Drug Adherence." Harvard Business School Case 515-010, January 2015. (Revised July 2019.) (Email mking@hbs.edu for a courtesy copy.)
- June 2021
- Case
HelloSelf: Search
By: John R. Wells and Benjamin Weinstock
In August 2018, after nearly six months of searching, Charles Wells was convinced that he should found HelloSelf to help people improve their sense of mental wellbeing. Those feeling mentally unwell would receive support from fully qualified clinical psychotherapists,... View Details
Keywords: Mental Health; Health Care and Treatment; Internet and the Web; Business Model; Product Launch
Wells, John R., and Benjamin Weinstock. "HelloSelf: Search." Harvard Business School Case 721-484, June 2021.
- October 2014 (Revised April 2023)
- Case
Gilead: Hepatitis C Access Strategy (A)
By: V. Kasturi Rangan, Vikram Rangan and David E. Bloom
Gilead had come up with an innovative drug for Hepatitis C, which affected 180 million people worldwide. The drug was priced at $1,000 a pill for the US market. Gilead had to decide how to price and market the pill in developing countries that bore the brunt of the... View Details
Keywords: Healthcare; Pharmaceuticals; Pricing; Access To Care; Emerging Markets; Health Care and Treatment; Price; Strategy; Ethics; Health Industry; Health Industry
Rangan, V. Kasturi, Vikram Rangan, and David E. Bloom. "Gilead: Hepatitis C Access Strategy (A)." Harvard Business School Case 515-025, October 2014. (Revised April 2023.)
- Web
Bringing the Next Pandemic Vaccine to Your Doorstep with MIMIX - Blog: Health Supplement
the Blavatnik Fellowship in Life Science Entrepreneurship and utilizing my experience to help the next generation of life science leaders making a difference in the world. About the author: Michael Schrader (MBA 2012) is the CEO View Details
- 13 Mar 2023
- Research & Ideas
The Power of Personal Connections: How Shared Experiences Boost Performance
Do relationships between colleagues raise the bar? A new analysis of how physicians who know each other provide better patient care could impart wide-ranging lessons for the... View Details
- September 2012
- Article
The Relationship Between Economic Preferences and Psychological Personality Measures
By: Anke Becker, Thomas Deckers, Thomas Dohmen, Armin Falk and Fabian Kosse
Although both economists and psychologists seek to identify determinants of heterogeneity in behavior, they use different concepts to capture them. In this review, we first analyze the extent to which economic preferences and psychological concepts of personality, such... View Details
Keywords: Risk Preference; Time Preference; Social Preferences; Locus Of Control; Big Five; Economics; Behavior; Personal Characteristics
Becker, Anke, Thomas Deckers, Thomas Dohmen, Armin Falk, and Fabian Kosse. "The Relationship Between Economic Preferences and Psychological Personality Measures." Annual Review of Economics 4 (September 2012): 453–478.
- August 2000
- Case
Developing Nurse Practitioners at the College of St. Catherine
By: Clayton M. Christensen and Sarah S. Khetani
Margaret McLaughlin has just begun her new appointment as the Dean of Health Professions at the College of St. Catherine in Minneapolis/St. Paul, Minnesota. As an education leader, her charge is to develop Minnesota's health care workforce for the future. She is... View Details
Keywords: Trends; Debates; Decision Choices and Conditions; Higher Education; Teaching; Growth and Development; Technological Innovation; Leading Change; Goals and Objectives; Value Creation; Health Industry
Christensen, Clayton M., and Sarah S. Khetani. "Developing Nurse Practitioners at the College of St. Catherine." Harvard Business School Case 601-039, August 2000.
- 22 Nov 2004
- Research & Ideas
Side Effects: The Case of Propecia
You are the marketing director of Propecia, a new drug for hair restoration that's about to hit the market. But the drug can only be purchased via a physician's prescription. So do you advertise directly to... View Details
- 2013
- Working Paper
An Empirical Study of the Spillover Effects of Workload on Patient Length of Stay
By: Jillian Berry Jaeker and Anita Tucker
We use two years of inpatient data from 243 California hospitals to quantify the relationship between hospital-level workload and patient length of stay (LOS), and its "spillover" effects across patient types. Patients are categorized as medical or surgical, and the... View Details
Keywords: Workload; Processing Times; Healthcare; Working Conditions; Performance Productivity; Time Management; Health Care and Treatment; Health Industry; California
Berry Jaeker, Jillian, and Anita Tucker. "An Empirical Study of the Spillover Effects of Workload on Patient Length of Stay." Harvard Business School Working Paper, No. 13-052, December 2012. (Revised July 2013.)
- September 1974
- Case
Max-Able Medical Clinic (A)
The issue concerns introduction of a new technology in health care delivery. The case requires the student to analyze the process for delivering health care via a new technology, the multiphasic testing facility. Analysis of patient flow, capacity, choice of tests, and... View Details
Keywords: Service Delivery; Technology Adoption; Health Care and Treatment; Health Industry; Health Industry
Abernathy, William. "Max-Able Medical Clinic (A)." Harvard Business School Case 675-040, September 1974.
- February 2022 (Revised November 2022)
- Case
Nuritas
By: Mitchell Weiss, Satish Tadikonda, Vincent Dessain and Emer Moloney
Nora Khaldi had built a technology “to unlock the power of nature” in the service of extending human lifespan and improving health, and now in April 2020 was debating telling her Board of Directors she wanted to put on ice some of her discoveries. Nuritas, the company... View Details
Keywords: Cash Burn; Cash Flow Analysis; Pharmaceutical Companies; Founder; Artificial Intelligence; AI; Entrepreneurship; Health Testing and Trials; Health Care and Treatment; Decision Making; Market Entry and Exit; AI and Machine Learning; Pharmaceutical Industry
Weiss, Mitchell, Satish Tadikonda, Vincent Dessain, and Emer Moloney. "Nuritas." Harvard Business School Case 822-080, February 2022. (Revised November 2022.)
- 2020
- Working Paper
Paying It Backward and Forward: Expanding Access to Convalescent Plasma Therapy Through Market Design
By: Scott Duke Kominers, Parag A. Pathak, Tayfun Sönmez and M. Utku Ünver
COVID-19 convalescent plasma (CCP) therapy is currently a leading treatment for COVID-19. At present, there is a shortage of CCP relative to demand. We develop and analyze a model of centralized CCP allocation that incorporates both donation and distribution. In order... View Details
Keywords: COVID-19; Convalescent Plasma; Vouchers; Health Pandemics; Health Care and Treatment; Resource Allocation; Market Design
Kominers, Scott Duke, Parag A. Pathak, Tayfun Sönmez, and M. Utku Ünver. "Paying It Backward and Forward: Expanding Access to Convalescent Plasma Therapy Through Market Design." Harvard Business School Working Paper, No. 20-116, May 2020. (NBER Working Paper Series, No. 27143, May 2020.)
- January 2017
- Supplement
Terrapin Laboratory: Exercise
By: Joseph B. Fuller and Christopher Payton
In this exercise, we examine the capital requirements of Terrapin Laboratory as they contemplate entering into a new market segment. The company is faced with two potential financing options which have different effects on the ownership structure of the company.... View Details